SynthesisInternational journal of molecular sciences2022

Janus Kinase Inhibitors Improve Disease Activity and Patient-Reported Outcomes in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of 24,135 Patients.

Lilla Tóth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.